This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study designs and other criteria for inclusion in the review
For the relationship between DGF and graft loss, the vast majority of studies were of an observational design (although this was not a stated criterion). For the relationship between DGF and long-term graft loss, focus was placed on studies that used proportional hazards analysis. Cox models for graft loss were based finally on one observational study.
Sources searched to identify primary studies
Fifteen electronic bibliographic databases were searched. In addition, article references and sponsor submissions were handsearched.
Criteria used to ensure the validity of primary studies
As this was a systematic review it is not possible to summarise the chosen methods. Full details were reported in Chapter 3 of the study.
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Eighteen studies were included for the relationship between DGF and graft loss. Of the 7 studies reporting Cox models for graft loss that were initially found, only two presented Kaplan-Meier survival for DGF versus no DGF. One of these studies was chosen as it allowed calibration of a model of graft loss.
Methods of combining primary studies
The authors adopted both univariate and multivariate proportional hazards analyses, in conjunction with Kaplan-Meier graft survival plots, to derive graft survival estimates dependent on DGF or no DGF. For the relationship between DGF and graft loss, a narrative summary was given. A meta-analysis was used to estimate the hazard of graft loss from DGF.
Investigation of differences between primary studies
The heterogeneity in the primary studies was described, and a rationale was provided for studies that eventually contributed to the modelling.
Results of the review
For the relationship between DGF and graft loss, the results showed that DGF is associated with higher rates of graft loss.
The rate ratios of allograft failure from the multivariate proportional hazards analysis were:
for delayed allograft function (any versus none), 1.72 (confidence interval, CI: 1.07 -2.76; p=0.02); for rejection (any versus none in first 30 days), 1.99 (CI: 1.23 -3.21; p<0.01); for rejection beyond 30 days, 3.53 (CI: 2.08 -6.00; p<0.01); for nonwhite versus white recipient race, 2.78 (CI: 1.78 -4.35; p<0.01); and prior renal transplant (any versus none), 1.38 (CI: 1.02 -1.87; p=0.04).
The Kaplan-Meier graft survival plots for 1, 3, 5 and 10 years showed that, for MP versus CS, the survival advantage ranged from 1 to 2% (HDB) and from 2 to 3% (NHBD). These values were not statistically significant because of the small trial sizes.
Measure of benefits used in the economic analysis
Two measures of health benefit were used in the economic analysis. These were cumulative graft-years lost when using CS in comparison with MP (cost-effectiveness elements), and the gain in quality-adjusted life-years (QALYs) with the use of MP. Graft-years lost were based on graft survival data derived from the systematic review. The utilities for the QALY analysis were obtained from a separate review of the literature. A score of 0.84 was assigned to a functioning transplant and a score of 0.65 to dialysis following graft failure. The health benefits were discounted at a rate of 1.5%, in accordance with UK Treasury guidelines.
Direct costs
As a health service perspective was chosen, only the direct costs were included. The costs and the quantities were reported separately. The direct costs covered graft loss, the short-term cost of DGF, and the machine preservation system. The cost of graft loss included hospitalisation, annual technician costs, and annual immunosuppressive maintenance therapy. The cost of the machine preservation system included maintenance, cassette, solution, purchase cost, machine plus starter pack, and personnel.
Discounting was appropriately applied at a rate of 6%. The dialysis costs were derived from the UK Prospective Diabetes Study Group and were adjusted to 2002 values. Continuous ambulatory peritoneal dialysis costs were derived from a study in the Trent Region. The costs associated with transplant maintenance were derived from a Trent Institute Guidance Note and the UK Medicines Information Service. The costs associated with the machine preservation system were based on the use of a Waters Corporation Medical System RM3 renal preservation system (actual system used by the Leicester General Hospital). The cost per transplant was based on data from the Renal and Liver Transplant Unit of the Freeman Hospital in Newcastle Upon Tyne.
Statistical analysis of costs
Uncertainty in the data was addressed in the sensitivity analysis.
Indirect Costs
The indirect costs were not assessed.
Currency
UK pounds sterling ().
Sensitivity analysis
The sensitivity of the long-term survival model was assessed by introducing random errors of the order of +/-3% into each of the 12-month interval hazard estimates. The Weibull model was then refitted to obtain new baseline parameter estimates. A sensitivity analysis, using lower and upper limits from the meta-analysis, was also performed to assess the error in estimating the hazard of graft loss from DGF. Uncertainty in the kidney preservation system model was addressed by means of probabilistic sensitivity analyses. Mean values and standard errors were derived from the literature, or assumed in some cases, and were applied to all parameters used in the model. Where prior distributions were unknown, uniform distributions based on minimum and maximum values were used. Standard errors for parameters with normal or log normal distributions were chosen to allow for wide uncertainty in the model. An Expected Value of Perfect Information (EVPI) analysis was also conducted on the model as a whole, and on individual parameters.
